| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 1.74e-18 | 26 | 76 | 10 | GO:0005248 |
| GeneOntologyMolecularFunction | sodium channel activity | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 4.80e-15 | 52 | 76 | 10 | GO:0005272 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 5.39e-10 | 26 | 76 | 6 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 9.55e-10 | 171 | 76 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | sodium ion binding | 1.36e-09 | 14 | 76 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 6.93e-08 | 343 | 76 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 1.78e-07 | 465 | 76 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 1.25e-06 | 459 | 76 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 4.09e-06 | 627 | 76 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | channel activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 4.57e-06 | 525 | 76 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 4.65e-06 | 526 | 76 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 7.32e-06 | 664 | 76 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 2.74e-05 | 758 | 76 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.47e-05 | 17 | 76 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 4.25e-05 | 793 | 76 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 2.12e-04 | 6 | 76 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.52e-04 | 182 | 76 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 6.85e-04 | 184 | 76 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 9.21e-04 | 12 | 76 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.26e-03 | 14 | 76 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 1.59e-03 | 1180 | 76 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.60e-03 | 20 | 76 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | transporter activity | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 3.31e-03 | 1289 | 76 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 4.21e-03 | 172 | 76 | 4 | GO:0044325 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.54e-15 | 36 | 77 | 9 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 9.12e-13 | 87 | 77 | 10 | GO:0086001 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.50e-12 | 62 | 77 | 9 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.75e-12 | 63 | 77 | 9 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 1.81e-12 | 93 | 77 | 10 | GO:0086003 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 4.23e-11 | 127 | 77 | 10 | GO:0070252 |
| GeneOntologyBiologicalProcess | actin filament-based movement | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 2.69e-10 | 153 | 77 | 10 | GO:0030048 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.51e-10 | 112 | 77 | 9 | GO:0019226 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 6.35e-10 | 167 | 77 | 10 | GO:0060048 |
| GeneOntologyBiologicalProcess | membrane depolarization | 7.03e-10 | 121 | 77 | 9 | GO:0051899 | |
| GeneOntologyBiologicalProcess | action potential | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 3.84e-09 | 201 | 77 | 10 | GO:0001508 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 5.34e-09 | 208 | 77 | 10 | GO:0035725 |
| GeneOntologyBiologicalProcess | striated muscle contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 8.01e-09 | 217 | 77 | 10 | GO:0006941 |
| GeneOntologyBiologicalProcess | sodium ion transport | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 7.53e-08 | 275 | 77 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | heart contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 1.59e-07 | 298 | 77 | 10 | GO:0060047 |
| GeneOntologyBiologicalProcess | heart process | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 2.23e-07 | 309 | 77 | 10 | GO:0003015 |
| GeneOntologyBiologicalProcess | muscle contraction | ARHGAP42 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 2.70e-07 | 400 | 77 | 11 | GO:0006936 |
| GeneOntologyBiologicalProcess | muscle system process | ARHGAP42 SCN1A SCN2A PARP2 SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 8.22e-07 | 547 | 77 | 12 | GO:0003012 |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 5.89e-06 | 10 | 77 | 3 | GO:0060371 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 6.95e-06 | 559 | 77 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 PRNP | 7.00e-06 | 922 | 77 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 PRNP | 8.93e-06 | 942 | 77 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.07e-05 | 12 | 77 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.07e-05 | 12 | 77 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | metal ion transport | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 PRNP | 1.75e-05 | 1000 | 77 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 PRNP | 2.11e-05 | 1017 | 77 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 2.20e-05 | 15 | 77 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | blood circulation | ARHGAP42 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 2.75e-05 | 648 | 77 | 11 | GO:0008015 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 PRNP | 5.77e-05 | 1115 | 77 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 8.21e-05 | 4 | 77 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | circulatory system process | ARHGAP42 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 8.36e-05 | 733 | 77 | 11 | GO:0003013 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 PRNP | 8.58e-05 | 1157 | 77 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 NF2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 1.35e-04 | 912 | 77 | 12 | GO:0030029 |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 1.37e-04 | 5 | 77 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 2.04e-04 | 6 | 77 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 2.30e-04 | 32 | 77 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 2.75e-04 | 34 | 77 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 2.85e-04 | 7 | 77 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 2.85e-04 | 7 | 77 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 3.80e-04 | 8 | 77 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 PRNP | 5.07e-04 | 1374 | 77 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | cardiac conduction | 5.37e-04 | 100 | 77 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 5.54e-04 | 43 | 77 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 6.07e-04 | 10 | 77 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 6.07e-04 | 10 | 77 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 7.40e-04 | 11 | 77 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 7.40e-04 | 11 | 77 | 2 | GO:0086070 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 7.95e-04 | 111 | 77 | 4 | GO:0006942 | |
| GeneOntologyBiologicalProcess | response to pain | 9.16e-04 | 51 | 77 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 9.57e-04 | 202 | 77 | 5 | GO:0006937 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 1.04e-03 | 13 | 77 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 1.04e-03 | 13 | 77 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 1.19e-03 | 317 | 77 | 6 | GO:0090257 | |
| GeneOntologyBiologicalProcess | negative thymic T cell selection | 1.22e-03 | 14 | 77 | 2 | GO:0045060 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.27e-03 | 57 | 77 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 1.39e-03 | 129 | 77 | 4 | GO:0002027 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 1.40e-03 | 59 | 77 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 1.40e-03 | 15 | 77 | 2 | GO:0086069 | |
| GeneOntologyBiologicalProcess | negative T cell selection | 1.40e-03 | 15 | 77 | 2 | GO:0043383 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 1.54e-03 | 61 | 77 | 3 | GO:0003254 | |
| GeneOntologyBiologicalProcess | behavior | NR2C2 SCN1A SCN2A SCN3A SCN8A SCN9A SCN10A ANKRD62 MAPK10 PRNP | 1.71e-03 | 891 | 77 | 10 | GO:0007610 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organism growth | 1.80e-03 | 17 | 77 | 2 | GO:0040015 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.83e-18 | 17 | 77 | 9 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 7.27e-16 | 29 | 77 | 9 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 1.51e-08 | 235 | 77 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 1.34e-07 | 378 | 77 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 4.45e-07 | 523 | 77 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 7.57e-07 | 550 | 77 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | node of Ranvier | 5.24e-05 | 20 | 77 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | intercalated disc | 1.16e-04 | 68 | 77 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CD3E CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 1.36e-04 | 785 | 77 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | axon initial segment | 1.64e-04 | 29 | 77 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.04e-04 | 94 | 77 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | axon | TUBB3 SCN1A KIF21A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A PRNP | 4.04e-04 | 891 | 77 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | microfibril | 1.02e-03 | 13 | 77 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | membrane protein complex | CD3E NALCN CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A UBAP1 CACNA1G ATP2A2 | 1.04e-03 | 1498 | 77 | 14 | GO:0098796 |
| GeneOntologyCellularComponent | platelet dense granule lumen | 1.18e-03 | 14 | 77 | 2 | GO:0031089 | |
| GeneOntologyCellularComponent | platelet dense granule | 2.69e-03 | 21 | 77 | 2 | GO:0042827 | |
| GeneOntologyCellularComponent | T-tubule | 3.11e-03 | 79 | 77 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.58e-03 | 277 | 77 | 5 | GO:0042734 | |
| HumanPheno | Brain imaging abnormality | 9.14e-07 | 167 | 34 | 9 | HP:0410263 | |
| HumanPheno | Pes valgus | 1.42e-06 | 56 | 34 | 6 | HP:0008081 | |
| HumanPheno | Dysgenesis of the hippocampus | 2.85e-06 | 16 | 34 | 4 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 2.85e-06 | 16 | 34 | 4 | HP:0011172 | |
| HumanPheno | Reflex seizure | 1.11e-05 | 22 | 34 | 4 | HP:0020207 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.49e-05 | 8 | 34 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.49e-05 | 8 | 34 | 3 | HP:0200048 | |
| HumanPheno | Focal hemiclonic seizure | 1.90e-05 | 25 | 34 | 4 | HP:0006813 | |
| HumanPheno | Limited knee extension | 2.61e-05 | 27 | 34 | 4 | HP:0003066 | |
| HumanPheno | Simple febrile seizure | 2.61e-05 | 27 | 34 | 4 | HP:0011171 | |
| HumanPheno | Abnormality of the calcaneus | 3.19e-05 | 57 | 34 | 5 | HP:0008364 | |
| HumanPheno | Abnormal exteroceptive sensation | 3.38e-05 | 259 | 34 | 9 | HP:0033747 | |
| HumanPheno | Limited neck range of motion | 4.32e-05 | 11 | 34 | 3 | HP:0000466 | |
| HumanPheno | Superior rectus atrophy | 4.32e-05 | 2 | 34 | 2 | HP:0012242 | |
| HumanPheno | Jaw pain | 4.32e-05 | 2 | 34 | 2 | HP:0040264 | |
| HumanPheno | Generalized tonic seizure | 5.61e-05 | 64 | 34 | 5 | HP:0010818 | |
| HumanPheno | Epilepsia partialis continua | 5.74e-05 | 12 | 34 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 5.74e-05 | 12 | 34 | 3 | HP:0032898 | |
| HumanPheno | Multifocal epileptiform discharges | 6.52e-05 | 66 | 34 | 5 | HP:0010841 | |
| HumanPheno | Generalized clonic seizure | 6.66e-05 | 34 | 34 | 4 | HP:0011169 | |
| HumanPheno | Calcaneovalgus deformity | 6.66e-05 | 34 | 34 | 4 | HP:0001848 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 7.43e-05 | 13 | 34 | 3 | HP:0007058 | |
| HumanPheno | Deformed tarsal bones | 7.48e-05 | 35 | 34 | 4 | HP:0008119 | |
| HumanPheno | Limitation of knee mobility | 7.48e-05 | 35 | 34 | 4 | HP:0010501 | |
| HumanPheno | Somatic sensory dysfunction | FBN1 NF2 NALCN SCN1A SCN4A SCN9A SCN10A UBAP1 CACNA1G PRNP RAI1 | 7.90e-05 | 439 | 34 | 11 | HP:0003474 |
| HumanPheno | Amblyopia | 8.04e-05 | 112 | 34 | 6 | HP:0000646 | |
| HumanPheno | Poor fine motor coordination | 8.08e-05 | 69 | 34 | 5 | HP:0007010 | |
| HumanPheno | Abnormality of pain sensation | 8.45e-05 | 113 | 34 | 6 | HP:0010832 | |
| HumanPheno | Apnea | 1.02e-04 | 372 | 34 | 10 | HP:0002104 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.08e-04 | 118 | 34 | 6 | HP:0011185 | |
| HumanPheno | Facial tics | 1.17e-04 | 15 | 34 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.17e-04 | 15 | 34 | 3 | HP:0007207 | |
| HumanPheno | Cerebral palsy | 1.23e-04 | 175 | 34 | 7 | HP:0100021 | |
| HumanPheno | Generalized non-motor (absence) seizure | 1.27e-04 | 176 | 34 | 7 | HP:0002121 | |
| HumanPheno | Abnormal upper to lower segment ratio | 1.29e-04 | 3 | 34 | 2 | HP:0012772 | |
| HumanPheno | Focal clonic seizure | 1.55e-04 | 42 | 34 | 4 | HP:0002266 | |
| HumanPheno | Focal motor status epilepticus | 1.73e-04 | 17 | 34 | 3 | HP:0032663 | |
| HumanPheno | Atypical absence status epilepticus | 1.73e-04 | 17 | 34 | 3 | HP:0011151 | |
| HumanPheno | Clonic seizure | 1.74e-04 | 81 | 34 | 5 | HP:0020221 | |
| HumanPheno | Abnormal autonomic nervous system physiology | 1.84e-04 | 130 | 34 | 6 | HP:0012332 | |
| HumanPheno | Dialeptic seizure | 1.84e-04 | 251 | 34 | 8 | HP:0011146 | |
| HumanPheno | Visually-induced seizure | 2.07e-04 | 18 | 34 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.07e-04 | 18 | 34 | 3 | HP:0032860 | |
| HumanPheno | Poor motor coordination | 2.19e-04 | 85 | 34 | 5 | HP:0002275 | |
| HumanPheno | Atypical absence seizure | 2.21e-04 | 46 | 34 | 4 | HP:0007270 | |
| HumanPheno | Abnormal knee physiology | 2.44e-04 | 87 | 34 | 5 | HP:0034670 | |
| HumanPheno | Gait ataxia | 2.55e-04 | 263 | 34 | 8 | HP:0002066 | |
| HumanPheno | Non-motor seizure | 2.57e-04 | 197 | 34 | 7 | HP:0033259 | |
| HumanPheno | Abnormal hippocampus morphology | 2.62e-04 | 48 | 34 | 4 | HP:0025100 | |
| HumanPheno | Sensory neuropathy | FBN1 NF2 NALCN SCN1A SCN4A SCN9A SCN10A UBAP1 CACNA1G PRNP RAI1 | 2.70e-04 | 503 | 34 | 11 | HP:0000763 |
| HumanPheno | Feeding difficulties in infancy | TUBB6 TUBB3 FBN1 NALCN SCN1A SCN3A SCN4A SCN9A KDM3B PLCH1 PCCA RAI1 | 2.73e-04 | 594 | 34 | 12 | HP:0008872 |
| HumanPheno | Abnormal morphology of the limbic system | 2.84e-04 | 49 | 34 | 4 | HP:0007343 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 2.87e-04 | 20 | 34 | 3 | HP:0032671 | |
| HumanPheno | Apathy | 3.01e-04 | 91 | 34 | 5 | HP:0000741 | |
| HumanPheno | Paresthesia | 3.22e-04 | 144 | 34 | 6 | HP:0003401 | |
| HumanPheno | Metatarsus adductus | 3.31e-04 | 51 | 34 | 4 | HP:0001840 | |
| HumanPheno | Talipes valgus | 3.33e-04 | 21 | 34 | 3 | HP:0004684 | |
| HumanPheno | Abnormal visual field test | 3.33e-04 | 21 | 34 | 3 | HP:0030588 | |
| HumanPheno | Dysesthesia | 3.33e-04 | 21 | 34 | 3 | HP:0012534 | |
| HumanPheno | Vertigo | 3.47e-04 | 146 | 34 | 6 | HP:0002321 | |
| HumanPheno | Diplopia | 3.50e-04 | 94 | 34 | 5 | HP:0000651 | |
| HumanPheno | Abnormality of binocular vision | 3.50e-04 | 94 | 34 | 5 | HP:0011514 | |
| HumanPheno | Visual acuity test abnormality | 3.84e-04 | 22 | 34 | 3 | HP:0030532 | |
| HumanPheno | Impulsivity | 3.87e-04 | 149 | 34 | 6 | HP:0100710 | |
| HumanPheno | Abnormal nervous system electrophysiology | FBN1 NALCN SCN1A KIF21A SCN2A SCN3A SCN4A SCN8A SCN9A UBAP1 CACNA1G PLCH1 MAPK10 PRNP RAI1 | 4.00e-04 | 924 | 34 | 15 | HP:0001311 |
| HumanPheno | Unsteady gait | 4.01e-04 | 357 | 34 | 9 | HP:0002317 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 4.27e-04 | 5 | 34 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 4.27e-04 | 5 | 34 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 4.27e-04 | 5 | 34 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 4.27e-04 | 5 | 34 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 4.27e-04 | 5 | 34 | 2 | HP:0032906 | |
| HumanPheno | Allodynia | 4.27e-04 | 5 | 34 | 2 | HP:0012533 | |
| HumanPheno | Tibial torsion | 4.39e-04 | 23 | 34 | 3 | HP:0100694 | |
| HumanPheno | Gaze-evoked nystagmus | 4.44e-04 | 55 | 34 | 4 | HP:0000640 | |
| HumanPheno | Cortical dysplasia | 4.76e-04 | 56 | 34 | 4 | HP:0002539 | |
| HumanPheno | Infantile muscular hypotonia | 4.91e-04 | 219 | 34 | 7 | HP:0008947 | |
| HumanPheno | Abnormality of central nervous system electrophysiology | NALCN SCN1A KIF21A SCN2A SCN3A SCN8A SCN9A UBAP1 CACNA1G PLCH1 MAPK10 PRNP RAI1 | 5.43e-04 | 738 | 34 | 13 | HP:0030178 |
| HumanPheno | Aphasia | 5.60e-04 | 104 | 34 | 5 | HP:0002381 | |
| HumanPheno | EEG abnormality | NALCN SCN1A SCN2A SCN3A SCN8A SCN9A CACNA1G PLCH1 MAPK10 PRNP RAI1 | 5.71e-04 | 548 | 34 | 11 | HP:0002353 |
| HumanPheno | Malignant hyperthermia | 6.36e-04 | 26 | 34 | 3 | HP:0002047 | |
| HumanPheno | Crumpled ear | 6.38e-04 | 6 | 34 | 2 | HP:0009901 | |
| HumanPheno | Levator palpebrae superioris atrophy | 6.38e-04 | 6 | 34 | 2 | HP:0012241 | |
| HumanPheno | Nonprogressive restrictive external ophthalmoplegia | 6.38e-04 | 6 | 34 | 2 | HP:0007831 | |
| HumanPheno | Abnormal pupil shape | 6.38e-04 | 6 | 34 | 2 | HP:0025309 | |
| HumanPheno | Limited vertical extraocular movement | 6.38e-04 | 6 | 34 | 2 | HP:0025721 | |
| HumanPheno | Normal interictal EEG | 6.38e-04 | 6 | 34 | 2 | HP:0002372 | |
| HumanPheno | Normal pressure hydrocephalus | 6.38e-04 | 6 | 34 | 2 | HP:0002343 | |
| HumanPheno | Congenital fibrosis of extraocular muscles | 6.38e-04 | 6 | 34 | 2 | HP:0001491 | |
| HumanPheno | Compensatory chin elevation | 6.38e-04 | 6 | 34 | 2 | HP:0001477 | |
| HumanPheno | Abnormal levator palpebrae superioris morphology | 6.38e-04 | 6 | 34 | 2 | HP:3000072 | |
| HumanPheno | Cerebellar atrophy | NALCN CACNA2D2 SCN1A ZNF335 SCN2A SCN8A CACNA1G PLCH1 RUBCN PRNP | 6.72e-04 | 468 | 34 | 10 | HP:0001272 |
| HumanPheno | Atrophy/Degeneration affecting the cerebellum | NALCN CACNA2D2 SCN1A ZNF335 SCN2A SCN8A CACNA1G PLCH1 RUBCN PRNP | 6.96e-04 | 470 | 34 | 10 | HP:0007368 |
| HumanPheno | Status epilepticus without prominent motor symptoms | 7.12e-04 | 27 | 34 | 3 | HP:0031475 | |
| HumanPheno | Abnormally increased volition | TUBB3 NALCN ACAT1 SCN1A SCN2A SCN3A SCN8A SCN9A KDM3B PLCH1 MAPK10 ATP2A2 PRNP RAI1 | 7.60e-04 | 869 | 34 | 14 | HP:5200263 |
| HumanPheno | Abnormal intestine morphology | DOCK2 CD3E FBN2 NF2 NALCN ACAT1 KIF21A SCN4A SCN9A SCN10A KDM3B UBAP1 CACNA1G PLCH1 PCCA ATP2A2 PRNP RAI1 RBCK1 | 7.65e-04 | 1459 | 34 | 19 | HP:0002242 |
| HumanPheno | Abnormality of temperature regulation | DOCK2 CD3E NALCN ACAT1 SCN4A SCN5A SCN9A SCN10A PLCH1 PRNP RBCK1 | 7.77e-04 | 568 | 34 | 11 | HP:0004370 |
| HumanPheno | Feeding difficulties | TUBB6 TUBB3 FBN1 NF2 NALCN SCN1A SCN3A SCN4A SCN9A KDM3B CACNA1G PLCH1 PCCA PRNP RAI1 | 7.89e-04 | 982 | 34 | 15 | HP:0002022 |
| HumanPheno | Focal aware seizure | 7.94e-04 | 28 | 34 | 3 | HP:0002349 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 8.82e-04 | 29 | 34 | 3 | HP:0032658 | |
| HumanPheno | Limb myoclonus | 8.82e-04 | 29 | 34 | 3 | HP:0045084 | |
| MousePheno | abnormal action potential | 4.09e-09 | 133 | 59 | 9 | MP:0005402 | |
| MousePheno | abnormal nervous system electrophysiology | NF2 NALCN CACNA2D2 SCN1A SCN2A SCN5A SCN8A SCN9A SCN10A CACNA1G KLHL18 RAI1 | 9.82e-09 | 329 | 59 | 12 | MP:0002272 |
| MousePheno | abnormal spike wave discharge | 2.86e-06 | 24 | 59 | 4 | MP:0008840 | |
| MousePheno | abnormal brain wave pattern | 7.10e-06 | 64 | 59 | 5 | MP:0004994 | |
| MousePheno | absence seizures | 1.36e-05 | 35 | 59 | 4 | MP:0003216 | |
| MousePheno | seizures | 1.82e-05 | 360 | 59 | 9 | MP:0002064 | |
| MousePheno | impaired ability to fire action potentials | 1.98e-05 | 13 | 59 | 3 | MP:0002578 | |
| MousePheno | nonconvulsive seizures | 2.33e-05 | 40 | 59 | 4 | MP:0000948 | |
| MousePheno | abnormal breathing pattern | 3.77e-05 | 303 | 59 | 8 | MP:0001951 | |
| MousePheno | abnormal motor coordination/balance | SERPINB5 SALL3 NF2 CACNA2D2 SCN1A SCN4A SCN8A SCN10A CACNA1G MAPK10 ATP2A2 PRNP RAI1 | 5.55e-05 | 873 | 59 | 13 | MP:0001516 |
| MousePheno | apnea | 1.94e-04 | 27 | 59 | 3 | MP:0001957 | |
| MousePheno | abnormal seizure response to inducing agent | 1.96e-04 | 201 | 59 | 6 | MP:0009357 | |
| MousePheno | decreased susceptibility to induction of seizure by inducing agent | 2.41e-04 | 29 | 59 | 3 | MP:0012348 | |
| MousePheno | decreased susceptibility to pharmacologically induced seizures | 2.41e-04 | 29 | 59 | 3 | MP:0002887 | |
| MousePheno | abnormal respiratory function | 2.55e-04 | 399 | 59 | 8 | MP:0002327 | |
| MousePheno | abnormal channel response | 3.56e-04 | 33 | 59 | 3 | MP:0003484 | |
| MousePheno | ventricular fibrillation | 3.63e-04 | 7 | 59 | 2 | MP:0006110 | |
| MousePheno | Purkinje cell degeneration | 3.74e-04 | 81 | 59 | 4 | MP:0000876 | |
| MousePheno | abnormal stationary movement | 3.81e-04 | 147 | 59 | 5 | MP:0001388 | |
| MousePheno | abnormal seizure response to pharmacological agent | 3.81e-04 | 147 | 59 | 5 | MP:0000950 | |
| MousePheno | abnormal single cell response | 4.25e-04 | 35 | 59 | 3 | MP:0003463 | |
| MousePheno | postnatal lethality | FBN1 CACNA2D2 SCN1A CBFA2T2 SCN2A SCN5A SCN8A SCN9A KDM3B FRYL NFAT5 PCCA RAI1 | 4.79e-04 | 1084 | 59 | 13 | MP:0002082 |
| Domain | Na_channel_asu | 1.84e-18 | 10 | 74 | 8 | IPR001696 | |
| Domain | Na_trans_assoc | 1.84e-18 | 10 | 74 | 8 | IPR010526 | |
| Domain | Na_trans_assoc | 1.84e-18 | 10 | 74 | 8 | PF06512 | |
| Domain | Na_trans_cytopl | 3.14e-15 | 6 | 74 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 3.14e-15 | 6 | 74 | 6 | IPR024583 | |
| Domain | Channel_four-helix_dom | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 1.89e-14 | 57 | 74 | 10 | IPR027359 |
| Domain | - | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 1.89e-14 | 57 | 74 | 10 | 1.20.120.350 |
| Domain | Ion_trans_dom | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 2.49e-11 | 114 | 74 | 10 | IPR005821 |
| Domain | Ion_trans | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G | 2.49e-11 | 114 | 74 | 10 | PF00520 |
| Domain | IQ_motif_EF-hand-BS | 2.46e-09 | 90 | 74 | 8 | IPR000048 | |
| Domain | IQ | 3.20e-09 | 93 | 74 | 8 | PS50096 | |
| Domain | IQ | 3.16e-08 | 81 | 74 | 7 | SM00015 | |
| Domain | IQ | 3.68e-07 | 71 | 74 | 6 | PF00612 | |
| Domain | Cell_morpho_N | 1.55e-05 | 2 | 74 | 2 | IPR025614 | |
| Domain | MOR2-PAG1_mid | 1.55e-05 | 2 | 74 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 1.55e-05 | 2 | 74 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 1.55e-05 | 2 | 74 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 1.55e-05 | 2 | 74 | 2 | PF14222 | |
| Domain | Cell_Morphogen_C | 1.55e-05 | 2 | 74 | 2 | IPR025481 | |
| Domain | FBN | 4.63e-05 | 3 | 74 | 2 | IPR011398 | |
| Domain | zf-RING_9 | 1.54e-04 | 5 | 74 | 2 | PF13901 | |
| Domain | DUF4206 | 1.54e-04 | 5 | 74 | 2 | SM01175 | |
| Domain | Zf-RING_9 | 1.54e-04 | 5 | 74 | 2 | IPR025258 | |
| Domain | TB | 3.21e-04 | 7 | 74 | 2 | PF00683 | |
| Domain | - | 4.27e-04 | 8 | 74 | 2 | 3.90.290.10 | |
| Domain | TB | 5.48e-04 | 9 | 74 | 2 | PS51364 | |
| Domain | TB_dom | 5.48e-04 | 9 | 74 | 2 | IPR017878 | |
| Domain | Beta-tubulin_BS | 6.83e-04 | 10 | 74 | 2 | IPR013838 | |
| Domain | Beta_tubulin | 6.83e-04 | 10 | 74 | 2 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 8.32e-04 | 11 | 74 | 2 | PS00228 | |
| Domain | VWA | 1.42e-03 | 56 | 74 | 3 | PF00092 | |
| Domain | - | 2.81e-03 | 20 | 74 | 2 | 3.30.1330.20 | |
| Domain | - | 3.10e-03 | 21 | 74 | 2 | 1.10.287.600 | |
| Domain | zf-MYND | 3.10e-03 | 21 | 74 | 2 | PF01753 | |
| Domain | Znf_MYND | 3.40e-03 | 22 | 74 | 2 | IPR002893 | |
| Domain | Tubulin_C | 3.40e-03 | 22 | 74 | 2 | SM00865 | |
| Domain | Tubulin_C | 3.40e-03 | 22 | 74 | 2 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 3.40e-03 | 22 | 74 | 2 | IPR018316 | |
| Domain | - | 3.40e-03 | 22 | 74 | 2 | 3.40.50.1440 | |
| Domain | ZF_MYND_1 | 3.40e-03 | 22 | 74 | 2 | PS01360 | |
| Domain | ZF_MYND_2 | 3.40e-03 | 22 | 74 | 2 | PS50865 | |
| Domain | Tubulin_C | 3.71e-03 | 23 | 74 | 2 | IPR023123 | |
| Domain | TUBULIN | 3.71e-03 | 23 | 74 | 2 | PS00227 | |
| Domain | Tubulin | 3.71e-03 | 23 | 74 | 2 | IPR000217 | |
| Domain | Tub_FtsZ_C | 3.71e-03 | 23 | 74 | 2 | IPR008280 | |
| Domain | Tubulin | 3.71e-03 | 23 | 74 | 2 | SM00864 | |
| Domain | Tubulin_CS | 3.71e-03 | 23 | 74 | 2 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 4.04e-03 | 24 | 74 | 2 | IPR003008 | |
| Domain | Tubulin | 4.04e-03 | 24 | 74 | 2 | PF00091 | |
| Domain | VWFA | 4.23e-03 | 82 | 74 | 3 | PS50234 | |
| Domain | VWA | 4.52e-03 | 84 | 74 | 3 | SM00327 | |
| Domain | cEGF | 4.73e-03 | 26 | 74 | 2 | IPR026823 | |
| Domain | cEGF | 4.73e-03 | 26 | 74 | 2 | PF12662 | |
| Domain | EF-hand-dom_pair | 5.62e-03 | 287 | 74 | 5 | IPR011992 | |
| Domain | EGF_Ca-bd_CS | 6.74e-03 | 97 | 74 | 3 | IPR018097 | |
| Domain | EGF_CA | 7.13e-03 | 99 | 74 | 3 | PS01187 | |
| Domain | VWF_A | 7.13e-03 | 99 | 74 | 3 | IPR002035 | |
| Domain | ASX_HYDROXYL | 7.33e-03 | 100 | 74 | 3 | PS00010 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 8.71e-15 | 32 | 62 | 9 | M27455 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.39e-13 | 31 | 62 | 8 | M877 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBB6 TUBB3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.10e-10 | 121 | 62 | 10 | M872 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A ATP2A2 | 2.25e-10 | 130 | 62 | 10 | M27454 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | CACNA2D2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 1.13e-09 | 203 | 62 | 11 | M5485 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TUBB6 TUBB3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ARHGAP39 PRNP | 9.98e-07 | 575 | 62 | 13 | M29853 |
| Pathway | WP_DRAVET_SYNDROME | 6.42e-06 | 28 | 62 | 4 | M45519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.18e-04 | 22 | 62 | 3 | M47903 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.74e-04 | 25 | 62 | 3 | M39713 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.94e-04 | 367 | 62 | 8 | M48346 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.96e-04 | 26 | 62 | 3 | M47672 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.73e-04 | 29 | 62 | 3 | MM15219 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 3.67e-04 | 32 | 62 | 3 | M27491 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2 | 3.94e-04 | 7 | 62 | 2 | M47976 | |
| Pathway | WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE | 5.24e-04 | 8 | 62 | 2 | M39906 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 1.07e-03 | 46 | 62 | 3 | M46450 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.14e-03 | 47 | 62 | 3 | M42524 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.14e-03 | 47 | 62 | 3 | M39829 | |
| Pubmed | 3.97e-21 | 9 | 78 | 8 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.05e-16 | 6 | 78 | 6 | 23652591 | |
| Pubmed | 3.67e-16 | 13 | 78 | 7 | 15123669 | ||
| Pubmed | 8.74e-15 | 9 | 78 | 6 | 15746173 | ||
| Pubmed | 4.98e-14 | 5 | 78 | 5 | 17724025 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA2D2 SCN1A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A CACNA1G ATP2A2 | 7.48e-13 | 139 | 78 | 10 | 16985003 |
| Pubmed | 2.34e-11 | 4 | 78 | 4 | 17537961 | ||
| Pubmed | 2.34e-11 | 4 | 78 | 4 | 35031483 | ||
| Pubmed | 2.34e-11 | 4 | 78 | 4 | 29578003 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 3.90e-11 | 12 | 78 | 5 | 30175250 | |
| Pubmed | 1.17e-10 | 5 | 78 | 4 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.17e-10 | 5 | 78 | 4 | 22875929 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 19284629 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 33895391 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 23859570 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 12610651 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 19699781 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 18784617 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 17544618 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 32845893 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 20038812 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 28518218 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 17928448 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 14973256 | ||
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 22260870 | ||
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 35801810 | ||
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 21156207 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 4.33e-08 | 4 | 78 | 3 | 8974318 | |
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 1679748 | ||
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 24337656 | ||
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 16029194 | ||
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 23711479 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.77e-07 | 7 | 78 | 3 | 25818041 | |
| Pubmed | 3.77e-07 | 7 | 78 | 3 | 15272007 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 3.77e-07 | 7 | 78 | 3 | 24440715 | |
| Pubmed | 6.03e-07 | 8 | 78 | 3 | 25101983 | ||
| Pubmed | 6.03e-07 | 8 | 78 | 3 | 9412493 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 9.03e-07 | 9 | 78 | 3 | 17884088 | |
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 9.03e-07 | 9 | 78 | 3 | 8854872 | |
| Pubmed | 2.35e-06 | 12 | 78 | 3 | 36779913 | ||
| Pubmed | 2.35e-06 | 12 | 78 | 3 | 8169823 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 4.84e-06 | 15 | 78 | 3 | 9726281 | |
| Pubmed | 4.84e-06 | 15 | 78 | 3 | 33722956 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12399449 | ||
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 4.97e-06 | 2 | 78 | 2 | 24642470 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21851253 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 4.97e-06 | 2 | 78 | 2 | 37901435 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 18079277 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 4.97e-06 | 2 | 78 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 4.97e-06 | 2 | 78 | 2 | 21440062 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15131124 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 4.97e-06 | 2 | 78 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 4.97e-06 | 2 | 78 | 2 | 10827969 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19694741 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 4.97e-06 | 2 | 78 | 2 | 11245985 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 4.97e-06 | 2 | 78 | 2 | 20404337 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15047701 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15760941 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 4.97e-06 | 2 | 78 | 2 | 8791520 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 4.97e-06 | 2 | 78 | 2 | 1317301 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22438565 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 4.97e-06 | 2 | 78 | 2 | 23016767 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 4.97e-06 | 2 | 78 | 2 | 8307578 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27153334 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 4.97e-06 | 2 | 78 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 4.97e-06 | 2 | 78 | 2 | 25172946 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31439038 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 4.97e-06 | 2 | 78 | 2 | 7744963 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 4.97e-06 | 2 | 78 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 4.97e-06 | 2 | 78 | 2 | 24833718 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31943325 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11834499 | ||
| Pubmed | Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome. | 4.97e-06 | 2 | 78 | 2 | 28556246 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 4.97e-06 | 2 | 78 | 2 | 15249644 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27690330 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24265020 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20529844 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23133647 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 4.97e-06 | 2 | 78 | 2 | 27174182 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 18601978 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 4.97e-06 | 2 | 78 | 2 | 24998131 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 4.97e-06 | 2 | 78 | 2 | 23965409 | |
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 4.97e-06 | 2 | 78 | 2 | 19465131 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 4.97e-06 | 2 | 78 | 2 | 1852206 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 4.97e-06 | 2 | 78 | 2 | 16847056 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24360055 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 4.97e-06 | 2 | 78 | 2 | 23735284 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 32330377 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 29649454 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12429739 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 4.97e-06 | 2 | 78 | 2 | 12524050 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 26861708 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 4.97e-06 | 2 | 78 | 2 | 16111501 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 8120105 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35419902 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 33096315 | ||
| Interaction | SCN11A interactions | 1.15e-11 | 15 | 76 | 6 | int:SCN11A | |
| Interaction | SCN5A interactions | 2.23e-08 | 47 | 76 | 6 | int:SCN5A | |
| Interaction | CACNA1D interactions | 2.68e-08 | 24 | 76 | 5 | int:CACNA1D | |
| Interaction | SCN1A interactions | 7.38e-08 | 29 | 76 | 5 | int:SCN1A | |
| Interaction | NALCN interactions | 1.82e-07 | 14 | 76 | 4 | int:NALCN | |
| Interaction | SCN9A interactions | 1.06e-06 | 21 | 76 | 4 | int:SCN9A | |
| Interaction | SCN4B interactions | 2.85e-06 | 8 | 76 | 3 | int:SCN4B | |
| Interaction | SCN10A interactions | 8.32e-06 | 11 | 76 | 3 | int:SCN10A | |
| Interaction | CACNA1B interactions | 1.12e-05 | 37 | 76 | 4 | int:CACNA1B | |
| Interaction | NEDD4L interactions | 2.73e-05 | 320 | 76 | 8 | int:NEDD4L | |
| Interaction | SNTA1 interactions | 4.80e-05 | 105 | 76 | 5 | int:SNTA1 | |
| Interaction | SCN8A interactions | 5.61e-05 | 20 | 76 | 3 | int:SCN8A | |
| Interaction | CACNA1A interactions | 1.02e-04 | 123 | 76 | 5 | int:CACNA1A | |
| Interaction | CAPS interactions | 1.12e-04 | 25 | 76 | 3 | int:CAPS | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 6.80e-05 | 127 | 78 | 4 | chr2q24 | |
| Cytoband | 2q24 | 1.55e-04 | 11 | 78 | 2 | 2q24 | |
| Cytoband | 2q24.3 | 3.37e-04 | 16 | 78 | 2 | 2q24.3 | |
| Cytoband | 4q32.3 | 1.54e-03 | 34 | 78 | 2 | 4q32.3 | |
| Cytoband | 18p11.21 | 3.31e-03 | 50 | 78 | 2 | 18p11.21 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.51e-20 | 9 | 56 | 8 | 1203 | |
| GeneFamily | Zinc fingers MYND-type | 1.91e-03 | 21 | 56 | 2 | 87 | |
| GeneFamily | Tubulins | 2.92e-03 | 26 | 56 | 2 | 778 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.92e-03 | 26 | 56 | 2 | 253 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | TUBB3 FRY NALCN SCN1A KIF21A SCN2A SCN3A SCN8A SCN9A CACNA1G CHCHD1 PTPRT | 9.42e-07 | 703 | 77 | 12 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TUBB3 FRY NALCN SCN1A KIF21A SCN2A SCN3A SCN8A SCN9A CACNA1G CLIP1 PTPRT PRNP RAI1 | 3.66e-06 | 1106 | 77 | 14 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 8.94e-06 | 465 | 77 | 9 | M39066 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | TUBB3 ACAT1 PARP2 SCN9A DZIP3 KDM3B UBAP1 ANKMY2 NFAT5 ATP2A2 CLIP1 RUBCN PRNP RBCK1 | 1.07e-05 | 1215 | 77 | 14 | M41122 |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP | 2.33e-05 | 194 | 77 | 6 | M3540 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 2.77e-05 | 200 | 77 | 6 | M3830 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 5.30e-05 | 450 | 77 | 8 | M39072 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.87e-06 | 211 | 74 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | TUBB6 TUBB3 SERPINB5 SCN2A SCN3A CRYBG1 MAPK10 PSAPL1 NFAT5 ATP2A2 FAM3D MFAP3L | 1.36e-05 | 772 | 74 | 12 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_200 | 1.82e-05 | 157 | 74 | 6 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.78e-05 | 108 | 74 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k4 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | TUBB6 TUBB3 FRY FBN1 FBN2 NALCN SCN2A SCN3A SCN9A MAPK10 PTPRT | 4.49e-05 | 734 | 74 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.20e-05 | 278 | 74 | 7 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_100 | 6.84e-05 | 23 | 74 | 3 | gudmap_developingKidney_e15.5_100_k2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 7.59e-05 | 125 | 74 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#5_top-relative-expression-ranked_200 | 9.90e-05 | 69 | 74 | 4 | gudmap_developingKidney_e15.5_Medullary collecting duct_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_100 | 1.12e-04 | 27 | 74 | 3 | gudmap_developingKidney_e15.5_cortic collect duct_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.13e-04 | 218 | 74 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_200 | 2.45e-04 | 35 | 74 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.49e-04 | 161 | 74 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 3.09e-04 | 371 | 74 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.88e-07 | 181 | 78 | 6 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-07 | 187 | 78 | 6 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.01e-06 | 189 | 78 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-06 | 190 | 78 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-06 | 194 | 78 | 6 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.41e-06 | 200 | 78 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.41e-06 | 200 | 78 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.41e-06 | 200 | 78 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.41e-06 | 200 | 78 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.41e-06 | 200 | 78 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.41e-06 | 200 | 78 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.25e-06 | 75 | 78 | 4 | 9a82db6281326acc534b800e02b262a8617a147e | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.25e-06 | 75 | 78 | 4 | 7678e7d514560c774b56fc0a20312d561c89f587 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.25e-06 | 75 | 78 | 4 | 7f1fc575fca42352434f7188c7a95b50372aeefa | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 164 | 78 | 5 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 164 | 78 | 5 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.16e-05 | 168 | 78 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 169 | 78 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 170 | 78 | 5 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 170 | 78 | 5 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-05 | 176 | 78 | 5 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-05 | 176 | 78 | 5 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 179 | 78 | 5 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-05 | 179 | 78 | 5 | 4808469096cd6bec2bdfcf4fc55aa324757600c3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-05 | 179 | 78 | 5 | 4d55718c6afd8a038d93cc77b9b08171dab9976f | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-05 | 180 | 78 | 5 | 6a2366d76276452141db1bd93013a9503525f574 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 180 | 78 | 5 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.66e-05 | 181 | 78 | 5 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 183 | 78 | 5 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 183 | 78 | 5 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.80e-05 | 184 | 78 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 187 | 78 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.99e-05 | 188 | 78 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 189 | 78 | 5 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 190 | 78 | 5 | bdbfaced785db79ff965f332759be258dbf743cf | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-05 | 190 | 78 | 5 | c44aae2e0d3cc84a187e12917fd8c2d7483f41d8 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 190 | 78 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 190 | 78 | 5 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-05 | 190 | 78 | 5 | 705489ebbaf3d8e643498c3e507742114475fc55 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 2.15e-05 | 191 | 78 | 5 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | Healthy-pDC|World / disease group, cell group and cell class | 2.15e-05 | 191 | 78 | 5 | 6e1d825dc33b915b95f13ccd237a552160a4be98 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-05 | 192 | 78 | 5 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 2.20e-05 | 192 | 78 | 5 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 192 | 78 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Healthy-pDC|Healthy / disease group, cell group and cell class | 2.20e-05 | 192 | 78 | 5 | 33d695a28d22b4af111df9591830a33bb7ef7b2d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 193 | 78 | 5 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 193 | 78 | 5 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 2.32e-05 | 194 | 78 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 2.32e-05 | 194 | 78 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.37e-05 | 195 | 78 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.37e-05 | 195 | 78 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.43e-05 | 196 | 78 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.49e-05 | 197 | 78 | 5 | 3a5908deb5c5a2bf06019a102fb1652233cf2a2a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 197 | 78 | 5 | a1ae1aa797762a3768e14434c7e5cd19c595ecb3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 197 | 78 | 5 | 5593721407f61fc5bc3f2f8bf8fa2604c4e29565 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 78 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 78 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 78 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 78 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 198 | 78 | 5 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-05 | 199 | 78 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-05 | 199 | 78 | 5 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-04 | 146 | 78 | 4 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 154 | 78 | 4 | ee03b386d28a524084eaf1c0091f7389daa34250 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 154 | 78 | 4 | 3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-04 | 155 | 78 | 4 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-04 | 156 | 78 | 4 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.71e-04 | 158 | 78 | 4 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 158 | 78 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 158 | 78 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 160 | 78 | 4 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 160 | 78 | 4 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-04 | 161 | 78 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-04 | 161 | 78 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-04 | 161 | 78 | 4 | 580153e131247e6ec12a1a920f050a0a763e7e87 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-04 | 161 | 78 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 162 | 78 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.97e-04 | 164 | 78 | 4 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-04 | 164 | 78 | 4 | c721047f1b7abc0d0a3e14bdaabd1a7181231b94 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 164 | 78 | 4 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-04 | 165 | 78 | 4 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 2.01e-04 | 165 | 78 | 4 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.01e-04 | 165 | 78 | 4 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 167 | 78 | 4 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 2.16e-04 | 168 | 78 | 4 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-04 | 168 | 78 | 4 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.16e-04 | 168 | 78 | 4 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.16e-04 | 168 | 78 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 169 | 78 | 4 | dcf92121fb00e3b6498e2648363e90ac044ea396 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-04 | 169 | 78 | 4 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 169 | 78 | 4 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 170 | 78 | 4 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 170 | 78 | 4 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 2.36e-04 | 172 | 78 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 2.36e-04 | 172 | 78 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 173 | 78 | 4 | 7c5e4809205ce1a0a301c15442af00a2e2b9b301 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-04 | 175 | 78 | 4 | bffa623511ceb0b9bf76d87f9a10cfadfe0e940f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-04 | 177 | 78 | 4 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 177 | 78 | 4 | a3f8c26d54e44688bbd678ac7ef55d8ad172617d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-04 | 177 | 78 | 4 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| Drug | Zonisamide | 6.59e-14 | 17 | 76 | 7 | DB00909 | |
| Drug | APETx1, Anthopleura elegantissima | 2.17e-12 | 6 | 76 | 5 | ctd:C475726 | |
| Drug | lamotrigine | 5.02e-09 | 116 | 76 | 8 | CID000003878 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 7.94e-09 | 8 | 76 | 4 | ctd:C489827 | |
| Drug | Sodium | 1.28e-08 | 84 | 76 | 7 | ctd:D012964 | |
| Drug | AC1L1MOZ | 2.76e-08 | 27 | 76 | 5 | CID000031958 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 3.57e-08 | 3 | 76 | 3 | ctd:C561228 | |
| Drug | procaine | 4.43e-08 | 153 | 76 | 8 | CID000004914 | |
| Drug | tocainide | 4.84e-08 | 30 | 76 | 5 | CID000038945 | |
| Drug | phenytoin | CACNA2D2 CYP4B1 SCN2A SCN3A SCN4A SCN5A SCN9A SCN10A CACNA1G | 4.87e-08 | 219 | 76 | 9 | CID000001775 |
| Drug | Lidocaine | 1.43e-07 | 4 | 76 | 3 | DB00281 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.43e-07 | 4 | 76 | 3 | ctd:C501880 | |
| Drug | benzocaine | 1.45e-07 | 37 | 76 | 5 | CID000002337 | |
| Drug | NSC7524 | 1.69e-07 | 182 | 76 | 8 | CID000005657 | |
| Drug | bepridil | 2.14e-07 | 126 | 76 | 7 | CID000002351 | |
| Drug | Tetrodotoxin | 2.18e-07 | 40 | 76 | 5 | ctd:D013779 | |
| Drug | Scorpion Venoms | 3.39e-07 | 18 | 76 | 4 | ctd:D012604 | |
| Drug | diprafenone | 4.28e-07 | 19 | 76 | 4 | CID000071249 | |
| Drug | pilsicainide | 4.47e-07 | 46 | 76 | 5 | CID000004820 | |
| Drug | fenpropathrin | 7.10e-07 | 6 | 76 | 3 | ctd:C044267 | |
| Drug | isradipine | 1.05e-06 | 100 | 76 | 6 | CID000003784 | |
| Drug | AC1NT1AF | 1.37e-06 | 25 | 76 | 4 | CID005322157 | |
| Drug | pyraclofos | 1.48e-06 | 106 | 76 | 6 | CID000093460 | |
| Drug | gabapentin | 1.56e-06 | 169 | 76 | 7 | CID000003446 | |
| Drug | Pirmenolum | 1.62e-06 | 26 | 76 | 4 | CID000004853 | |
| Drug | riluzole | 1.89e-06 | 174 | 76 | 7 | CID000005070 | |
| Drug | PbTx-1 | 1.90e-06 | 27 | 76 | 4 | CID006437089 | |
| Drug | nefopam | 1.90e-06 | 27 | 76 | 4 | CID000004450 | |
| Drug | zonisamide | 2.02e-06 | 62 | 76 | 5 | CID000005734 | |
| Drug | paraben | 2.21e-06 | 28 | 76 | 4 | CID000007175 | |
| Drug | saxitoxin | 2.56e-06 | 65 | 76 | 5 | CID000037165 | |
| Drug | AC1L1CQC | 2.56e-06 | 65 | 76 | 5 | CID000002012 | |
| Drug | mexiletine | 2.76e-06 | 66 | 76 | 5 | CID000004178 | |
| Drug | disopyramide | 2.76e-06 | 66 | 76 | 5 | CID000003114 | |
| Drug | Mexiletine | 2.96e-06 | 9 | 76 | 3 | ctd:D008801 | |
| Drug | dibucaine | 3.21e-06 | 68 | 76 | 5 | CID000003025 | |
| Drug | NSC93767 | 3.84e-06 | 32 | 76 | 4 | CID000005658 | |
| Drug | flecainide | 3.98e-06 | 71 | 76 | 5 | CID000003355 | |
| Drug | 1, 3-diallylurea | 4.88e-06 | 74 | 76 | 5 | CID000074537 | |
| Drug | 5-hydroxypropafenone | 4.93e-06 | 34 | 76 | 4 | CID000107927 | |
| Drug | aprindine | 7.76e-06 | 38 | 76 | 4 | CID000002218 | |
| Drug | quindine | 8.62e-06 | 219 | 76 | 7 | CID000001065 | |
| Drug | ranolazine | 8.63e-06 | 39 | 76 | 4 | CID000056959 | |
| Drug | decamethrin | 9.48e-06 | 146 | 76 | 6 | ctd:C017180 | |
| Drug | S-ropivacaine | 9.56e-06 | 40 | 76 | 4 | CID000071273 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 1.10e-05 | 2 | 76 | 2 | ctd:C502265 | |
| Drug | Hexylcaine | 1.10e-05 | 2 | 76 | 2 | DB00473 | |
| Drug | Ranolazine | 1.10e-05 | 2 | 76 | 2 | DB00243 | |
| Drug | Phenytoin | 1.10e-05 | 2 | 76 | 2 | DB00252 | |
| Drug | Flecainide | 1.10e-05 | 2 | 76 | 2 | DB01195 | |
| Drug | tetradotoxin | 1.26e-05 | 428 | 76 | 9 | CID000020382 | |
| Drug | BMPDA | 1.27e-05 | 14 | 76 | 3 | CID000119352 | |
| Drug | amiodarone | 1.60e-05 | 160 | 76 | 6 | CID000002156 | |
| Drug | spiradoline | 1.68e-05 | 46 | 76 | 4 | CID000005620 | |
| Drug | propafenone | 1.93e-05 | 98 | 76 | 5 | CID000004932 | |
| Drug | trimethoprim | 2.03e-05 | 99 | 76 | 5 | CID000005578 | |
| Drug | indoxacarb | 2.17e-05 | 49 | 76 | 4 | CID000107720 | |
| Drug | moricizine | 2.81e-05 | 18 | 76 | 3 | CID000034632 | |
| Drug | carbamazepine | 3.01e-05 | 179 | 76 | 6 | CID000002554 | |
| Drug | AC1NSN3X | 3.19e-05 | 54 | 76 | 4 | CID005366189 | |
| Drug | Dibucaine | 3.29e-05 | 3 | 76 | 2 | DB00527 | |
| Drug | valproate | 4.00e-05 | 381 | 76 | 8 | CID000003121 | |
| Drug | procainamide | 4.20e-05 | 190 | 76 | 6 | CID000004913 | |
| Drug | triamterene | 4.24e-05 | 58 | 76 | 4 | CID000005546 | |
| Drug | BDF 9148 | 4.55e-05 | 21 | 76 | 3 | CID000123765 | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; HL60; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 3017_UP | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; HL60; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 2458_DN | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; MCF7; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 7513_UP | |
| Drug | Fospropofol | 6.57e-05 | 4 | 76 | 2 | DB06716 | |
| Drug | Propofol | 6.57e-05 | 4 | 76 | 2 | DB00818 | |
| Drug | resiniferatoxin | 7.06e-05 | 66 | 76 | 4 | CID000104826 | |
| Drug | Multicide | 7.80e-05 | 25 | 76 | 3 | CID000024365 | |
| Drug | batrachotoxinin A 20-alpha-benzoate | 7.80e-05 | 25 | 76 | 3 | CID005485225 | |
| Drug | GBR 12909 | 8.41e-05 | 69 | 76 | 4 | CID000003455 | |
| Drug | T2755 | 9.40e-05 | 71 | 76 | 4 | CID000005514 | |
| Drug | amphotericin B derivative | 1.09e-04 | 5 | 76 | 2 | CID005386267 | |
| Drug | encainide | 1.10e-04 | 28 | 76 | 3 | CID000048040 | |
| Drug | DPI 201-106 | 1.10e-04 | 28 | 76 | 3 | CID000005190 | |
| Drug | imide | 1.10e-04 | 74 | 76 | 4 | CID000443040 | |
| Drug | isofagomine | 1.16e-04 | 75 | 76 | 4 | CID000447607 | |
| Drug | diphenhydramine | 1.16e-04 | 75 | 76 | 4 | CID000003100 | |
| Drug | potassium | CACNA2D2 ACAT1 CBFA2T2 SCN2A SCN3A SCN4A SCN5A SCN9A SCN10A CACNA1G PLCH1 ATP2A2 | 1.20e-04 | 1008 | 76 | 12 | CID000000813 |
| Drug | cyfluthrin | 1.23e-04 | 29 | 76 | 3 | ctd:C052570 | |
| Drug | AC1NBBHE | 1.36e-04 | 30 | 76 | 3 | CID004490620 | |
| Drug | oxcarbazepine | 1.36e-04 | 30 | 76 | 3 | CID000034312 | |
| Drug | lead compounds | 1.47e-04 | 150 | 76 | 5 | CID000073212 | |
| Drug | bupropion | 1.57e-04 | 81 | 76 | 4 | CID000000444 | |
| Drug | lead tetraacetate | 1.64e-04 | 6 | 76 | 2 | ctd:C029433 | |
| Drug | NSC15627 | 1.99e-04 | 34 | 76 | 3 | CID000002073 | |
| Drug | lidocaine | 1.99e-04 | 160 | 76 | 5 | CID000003676 | |
| Drug | verapamil | 2.27e-04 | 490 | 76 | 8 | CID000002520 | |
| Drug | fluorocyclobutane | 2.28e-04 | 7 | 76 | 2 | CID011051569 | |
| Drug | AA100 | 2.28e-04 | 7 | 76 | 2 | CID010490261 | |
| Drug | sipatrigine | 2.56e-04 | 37 | 76 | 3 | CID000060803 | |
| Drug | benzimidazole | 2.67e-04 | 93 | 76 | 4 | CID000005798 | |
| Drug | Cocaine | 3.04e-04 | 8 | 76 | 2 | DB00907 | |
| Drug | fenfluramine | 3.26e-04 | 178 | 76 | 5 | CID000003337 | |
| Drug | nalidixic acid | 3.29e-04 | 277 | 76 | 6 | CID000004421 | |
| Drug | isoproterenol | 3.81e-04 | 669 | 76 | 9 | CID000003779 | |
| Drug | cyclaine | 3.90e-04 | 9 | 76 | 2 | CID000010770 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 6.50e-19 | 12 | 76 | 8 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.98e-10 | 163 | 76 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.52e-09 | 22 | 76 | 5 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.36e-06 | 9 | 76 | 3 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 4.61e-06 | 13 | 76 | 3 | C0751122 | |
| Disease | congenital fibrosis of the extraocular muscles (implicated_via_orthology) | 6.55e-06 | 2 | 76 | 2 | DOID:0080143 (implicated_via_orthology) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 6.55e-06 | 2 | 76 | 2 | C4551549 | |
| Disease | Epilepsy | 9.40e-06 | 109 | 76 | 5 | C0014544 | |
| Disease | Scrapie | 1.96e-05 | 3 | 76 | 2 | C0036457 | |
| Disease | B Virus Infection | 1.96e-05 | 3 | 76 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 1.96e-05 | 3 | 76 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 1.96e-05 | 3 | 76 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 1.96e-05 | 3 | 76 | 2 | C0019372 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.96e-05 | 3 | 76 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Congenital fibrosis of extraocular muscles | 1.96e-05 | 3 | 76 | 2 | cv:C1302995 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.96e-05 | 3 | 76 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 1.96e-05 | 3 | 76 | 2 | C0014805 | |
| Disease | Congenital Fibrosis of the Extraocular Muscles | 1.96e-05 | 3 | 76 | 2 | C1302995 | |
| Disease | Intellectual Disability | 2.00e-05 | 447 | 76 | 8 | C3714756 | |
| Disease | Mental Retardation, Psychosocial | 3.05e-05 | 139 | 76 | 5 | C0025363 | |
| Disease | Profound Mental Retardation | 3.05e-05 | 139 | 76 | 5 | C0020796 | |
| Disease | Mental deficiency | 3.05e-05 | 139 | 76 | 5 | C0917816 | |
| Disease | bipolar I disorder | 3.26e-05 | 141 | 76 | 5 | EFO_0009963 | |
| Disease | scoliosis (is_implicated_in) | 3.92e-05 | 4 | 76 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Brugada ECG Pattern | 3.92e-05 | 4 | 76 | 2 | C1721096 | |
| Disease | Lennox-Gastaut syndrome | 9.75e-05 | 6 | 76 | 2 | C0238111 | |
| Disease | Familial benign neonatal epilepsy | 9.75e-05 | 6 | 76 | 2 | C0220669 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.36e-04 | 7 | 76 | 2 | C0020075 | |
| Disease | Seizure, Febrile, Simple | 1.36e-04 | 7 | 76 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.36e-04 | 7 | 76 | 2 | C0751057 | |
| Disease | electrocardiography, PR interval | 1.36e-04 | 7 | 76 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Congenital Pain Insensitivity | 1.36e-04 | 7 | 76 | 2 | C0002768 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.81e-04 | 8 | 76 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 1.81e-04 | 8 | 76 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 1.81e-04 | 8 | 76 | 2 | C0393703 | |
| Disease | Febrile Convulsions | 2.33e-04 | 9 | 76 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 2.33e-04 | 9 | 76 | 2 | C0014550 | |
| Disease | supraventricular ectopy | 2.33e-04 | 9 | 76 | 2 | EFO_0009277 | |
| Disease | Epilepsy, Myoclonic, Infantile | 2.91e-04 | 10 | 76 | 2 | C0917800 | |
| Disease | facial paralysis (implicated_via_orthology) | 2.91e-04 | 10 | 76 | 2 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 2.91e-04 | 10 | 76 | 2 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 2.91e-04 | 10 | 76 | 2 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 2.91e-04 | 10 | 76 | 2 | DOID:0112227 (implicated_via_orthology) | |
| Disease | Myoclonic Astatic Epilepsy | 3.55e-04 | 11 | 76 | 2 | C0393702 | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 4.25e-04 | 12 | 76 | 2 | DOID:0050997 (implicated_via_orthology) | |
| Disease | Creutzfeldt-Jakob Disease, Familial | 5.01e-04 | 13 | 76 | 2 | C0751254 | |
| Disease | Creutzfeldt-Jakob disease | 5.01e-04 | 13 | 76 | 2 | C0022336 | |
| Disease | Brugada Syndrome 1 | 5.01e-04 | 13 | 76 | 2 | C4551804 | |
| Disease | New Variant Creutzfeldt-Jakob Disease | 5.01e-04 | 13 | 76 | 2 | C0376329 | |
| Disease | T wave morphology measurement | 5.84e-04 | 14 | 76 | 2 | EFO_0008398 | |
| Disease | MMR-related febrile seizures | 6.73e-04 | 15 | 76 | 2 | EFO_0006519 | |
| Disease | P wave duration | 6.73e-04 | 15 | 76 | 2 | EFO_0005094 | |
| Disease | Neuralgia, Supraorbital | 7.67e-04 | 16 | 76 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 7.67e-04 | 16 | 76 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 7.67e-04 | 16 | 76 | 2 | C0423711 | |
| Disease | Tremor, Rubral | 7.67e-04 | 16 | 76 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 7.67e-04 | 16 | 76 | 2 | C0750937 | |
| Disease | Neuralgia | 7.67e-04 | 16 | 76 | 2 | C0027796 | |
| Disease | Ataxia, Motor | 7.67e-04 | 16 | 76 | 2 | C0278161 | |
| Disease | Abnormal coordination | 7.67e-04 | 16 | 76 | 2 | C0520966 | |
| Disease | Romano-Ward Syndrome | 7.67e-04 | 16 | 76 | 2 | C0035828 | |
| Disease | Ataxia, Truncal | 7.67e-04 | 16 | 76 | 2 | C0427190 | |
| Disease | Neuralgia, Atypical | 7.67e-04 | 16 | 76 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 7.67e-04 | 16 | 76 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 7.67e-04 | 16 | 76 | 2 | C0751373 | |
| Disease | Nerve Pain | 7.67e-04 | 16 | 76 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 7.67e-04 | 16 | 76 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 7.67e-04 | 16 | 76 | 2 | C0042656 | |
| Disease | Ataxia, Sensory | 7.67e-04 | 16 | 76 | 2 | C0240991 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 7.67e-04 | 16 | 76 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 9.75e-04 | 18 | 76 | 2 | HP_0002373 | |
| Disease | Disorder of organic acid metabolism | 9.75e-04 | 18 | 76 | 2 | cv:C1263739 | |
| Disease | Brugada syndrome | 1.09e-03 | 19 | 76 | 2 | MONDO_0015263 | |
| Disease | Epilepsy, Cryptogenic | 1.26e-03 | 82 | 76 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.26e-03 | 82 | 76 | 3 | C0751111 | |
| Disease | Aura | 1.26e-03 | 82 | 76 | 3 | C0236018 | |
| Disease | coffee consumption measurement | 1.27e-03 | 182 | 76 | 4 | EFO_0006781 | |
| Disease | diet measurement | 1.48e-03 | 1049 | 76 | 9 | EFO_0008111 | |
| Disease | Brugada Syndrome (disorder) | 1.74e-03 | 24 | 76 | 2 | C1142166 | |
| Disease | Neurodevelopmental Disorders | 1.80e-03 | 93 | 76 | 3 | C1535926 | |
| Disease | Ataxia | 1.89e-03 | 25 | 76 | 2 | C0004134 | |
| Disease | sexual dimorphism measurement | 2.12e-03 | 1106 | 76 | 9 | EFO_0021796 | |
| Disease | cardiovascular age measurement | 2.54e-03 | 29 | 76 | 2 | EFO_0803380 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NITRANCNKMIMMFT | 386 | Q9NY47 | |
| AMSMIQAITSKQEEM | 86 | A8MVX0 | |
| QMRSQVCMKLSMSTV | 901 | A6NC57 | |
| EVMMQIDCQVMDTRI | 611 | P18850 | |
| VMNMKIEETTMTTQT | 711 | Q14624 | |
| QEAMKVAVDMMCSSC | 1846 | Q7Z5J4 | |
| QMMSVLMNTIVFEDC | 981 | Q9H2T7 | |
| KCLEMGMKMESVQSE | 176 | P49116 | |
| MIISAMEKMKCNILS | 216 | Q9H714 | |
| KMDVSNLAMVMAPNC | 1031 | Q9C0H5 | |
| LIKLICNVQAMEEMM | 241 | Q9UGN5 | |
| AMCCMQMVSSDVLQM | 196 | O60320 | |
| LIMNCRTIMEEIMEV | 246 | O75121 | |
| TMCFEDRMIMSPVKN | 81 | Q96BQ1 | |
| MELMDANLCQVIQME | 146 | P53779 | |
| TTEMLKVMLQQGEAM | 431 | Q9BYM8 | |
| NCIMEMVEKTRRSMA | 356 | O43439 | |
| MTIMNRETCNKMLLG | 131 | Q8NH73 | |
| CMTSVQMSNKEPEDM | 531 | O94915 | |
| DQFCQLVMSEKEAMM | 996 | Q7LBC6 | |
| VKNSMESMNTDMVII | 481 | Q9P215 | |
| MQLACVDTSLNEMEM | 186 | Q8N628 | |
| EICVIEAMKMQNSMT | 686 | P05165 | |
| ESSAAMVMEMQQSIC | 891 | O94916 | |
| FLVMKMMIQENEICE | 161 | Q86Y13 | |
| MMIQENEICENFMSL | 166 | Q86Y13 | |
| MTEEEKIVCAMQMSL | 766 | A2A3N6 | |
| IVTMDAEMEFNCEMK | 26 | P35240 | |
| SVVMLNEMDTAQFCM | 1271 | O14522 | |
| NECSEVMSNMVSENM | 371 | P04070 | |
| KEPQIQMTVTMCKQM | 141 | Q96PS1 | |
| QMTVTMCKQMLRSIL | 146 | Q96PS1 | |
| AQGISMEAMSENKMV | 51 | Q6PI98 | |
| MTMALSVLVTIEMCN | 896 | P16615 | |
| ITEMSVMMACWKQNE | 46 | Q96BP2 | |
| MFTNDMMECKQDEIV | 66 | O94889 | |
| RFVCEMTNLQKEMQM | 946 | Q8NCX0 | |
| TMSTANEKILMMINQ | 1501 | Q92608 | |
| VVLMKTMDNVATFCM | 856 | O43497 | |
| MMMKNCMDIDECQRD | 1106 | P35555 | |
| LQKQLMELLDMVCMD | 131 | Q9NSG2 | |
| SMLTCKAAMRTMIQQ | 111 | Q8N4T8 | |
| EKCMKQRDMNEVLAM | 206 | Q8IV38 | |
| NCMEMDVMSVATIVI | 121 | P07766 | |
| QQFAMSEMKVVTAMC | 456 | P13584 | |
| DKEVGRCMMLTNVQM | 571 | Q5TBA9 | |
| CTKLMELNMEIRDMI | 2976 | Q5TBA9 | |
| TEIIKQMDSAVCMPM | 701 | Q9Y4K1 | |
| MMMKNCMDIDECERN | 1151 | P35556 | |
| IELMKCNMMSQCLEE | 506 | Q92622 | |
| AALENQMKMIDSVMS | 841 | Q9BXA9 | |
| QMKMIDSVMSCQQLT | 846 | Q9BXA9 | |
| AMQIMEQMTKEKTET | 1091 | P30622 | |
| VVMQFIMEMAKNCNV | 221 | Q7L3B6 | |
| TQQIMINDICSDMMC | 4281 | Q685J3 | |
| VQVTQVEEDMVMVLM | 711 | Q92918 | |
| MQMKAGVTCEVCMNV | 286 | Q6NUJ1 | |
| ILICLNMVTMMVETD | 1361 | P35499 | |
| MRAQEETVAAMMNIK | 541 | A6NI28 | |
| FLICLNMVTMMVETD | 1536 | Q14524 | |
| CLNMVTMMVEKEGQS | 1526 | Q15858 | |
| DTKPVQMMNMEATFC | 191 | P36952 | |
| MAIMSNKVCKTMVIC | 131 | A6NDL8 | |
| TINKVCASGMKAIMM | 121 | P24752 | |
| ICLNMVTMMVETDDQ | 1536 | Q9NY46 | |
| CSQVLGMSVMNKDMD | 736 | Q7Z745 | |
| ICLNMVTMMVETDDQ | 1551 | P35498 | |
| CEMLSKMVMETKTDN | 701 | Q8TBZ0 | |
| MMSICLQSMVDELMV | 371 | Q15036 | |
| NMKICEMVDESPAMC | 36 | Q96N38 | |
| QCSEEKMMEFLQLMS | 451 | Q9NZ09 | |
| MSMKEVDEQMLAIQS | 321 | Q9BUF5 | |
| TDIIMQKMTISNMEA | 931 | Q7Z4S6 | |
| ICLNMITMMVETDDQ | 1486 | Q9Y5Y9 | |
| CKQKDLLEQMMAEMI | 231 | Q9H4I3 | |
| ICLNMVTMMVETDDQ | 1541 | Q99250 | |
| TDVKMMERVVEQMCI | 201 | P04156 | |
| LICLNMVTMMVETDT | 1531 | Q9UQD0 | |
| MVTMMVETDTQSKQM | 1536 | Q9UQD0 | |
| MSMKEVDEQMLAIQS | 321 | Q13509 | |
| ERCMSVMQSGTQMIK | 16 | Q4KWH8 | |
| MQQCTEDRMPMNVKS | 576 | Q08AG5 | |
| QAEMMQSHMVKDICL | 431 | A3KMH1 | |
| MMEVVVVQQFKCKMC | 236 | Q9H4Z2 | |
| MKSVVCKMNPMTDAA | 1696 | Q8IZF0 |